Cargando…

Polypharmacy and oral antidiabetic treatment for type 2 diabetes characterised by drug class and patient characteristics: A Japanese database analysis

Polypharmacy (PP) occurs in patients with type 2 diabetes (T2DM) owing to multimorbidity. We evaluated concomitant PP and medication adherence in T2DM 3 years after initiation of administration of a hypoglycaemic agent using a nationwide claim-based database in Japan. Factors associated with medicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horii, Takeshi, Iwasawa, Makiko, Kabeya, Yusuke, Atuda, Koichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736933/ https://www.ncbi.nlm.nih.gov/pubmed/31506542 http://dx.doi.org/10.1038/s41598-019-49424-2

Ejemplares similares

Investigating the risk of bone fractures in elderly patients with type 2 diabetes mellitus: a retrospective study
por: Horii, Takeshi, et al.
Publicado: (2019)

Persistence of oral antidiabetic treatment for type 2 diabetes characterized by drug class, patient characteristics and severity of renal impairment: A Japanese database analysis
por: Kadowaki, Takashi, et al.
Publicado: (2018)

Determination of factors affecting medication adherence in type 2 diabetes mellitus patients using a nationwide claim-based database in Japan
por: Horii, Takeshi, et al.
Publicado: (2019)

Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
por: Negishi, Akio, et al.
Publicado: (2020)

Effects of pharmacist intervention on polypharmacy in patients with type 2 diabetes in Japan
por: Horii, Takeshi, et al.
Publicado: (2020)

Comparing treatment intensification and clinical outcomes of metformin and dipeptidyl peptidase‐4 inhibitors in treatment‐naïve patients with type 2 diabetes in Japan
por: Horii, Takeshi, et al.
Publicado: (2019)

Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study
por: Sato, Izumi, et al.
Publicado: (2013)

Analysis of polypharmacy effects in older patients using Japanese Adverse Drug Event Report database
por: Abe, Junko, et al.
Publicado: (2017)

Gliptins: A New Class of Oral Antidiabetic Agents
por: Seshadri, K. G., et al.
Publicado: (2009)

Characterisation of major histocompatibility complex class I genes in Japanese Ranidae frogs
por: Lau, Quintin, et al.
Publicado: (2016)

Pharmacogenetics of new classes of antidiabetic drugs
por: Kadrić, Selma Imamović, et al.
Publicado: (2021)

Efficacy of ipragliflozin as monotherapy or as add‐on therapy with other oral antidiabetic medications for treating type 2 diabetes in Japanese patients with inadequate glycemic control: A subgroup analysis based on patient characteristics
por: Osonoi, Takeshi, et al.
Publicado: (2017)

Pharmacogenetics of Oral Antidiabetic Drugs
por: Becker, Matthijs L., et al.
Publicado: (2013)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
por: Lo, Chris Wai Hang, et al.
Publicado: (2021)

CHARACTERISING POLYPHARMACY IN THE VERY OLD: FINDINGS FROM THE NEWCASTLE 85+ STUDY
por: Davies, Laurie, et al.
Publicado: (2019)

Characterising polypharmacy in the very old: Findings from the Newcastle 85+ Study
por: Davies, Laurie E., et al.
Publicado: (2021)

Use of the Japanese health insurance claims database to assess the risk of acute pancreatitis in patients with diabetes: comparison of DPP-4 inhibitors with other oral antidiabetic drugs
por: Yabe, D, et al.
Publicado: (2015)

Polypharmacy and Clinical Outcomes in Hospitalized Patients With Acute Decompensated Heart Failure
por: Ozasa, Neiko, et al.
Publicado: (2023)

Dietary Approaches for Japanese Patients with Diabetes: A Systematic Review
por: Yamada, Satoru, et al.
Publicado: (2018)

Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study
por: Ayani, Nobutaka, et al.
Publicado: (2021)

Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis
por: Iwasawa, Kentaro, et al.
Publicado: (2017)

Efficacy and safety of luseogliflozin added to various oral antidiabetic drugs in Japanese patients with type 2 diabetes mellitus
por: Seino, Yutaka, et al.
Publicado: (2015)

Remission of hyperglycemia after withdrawal of oral antidiabetic drugs in Japanese patients with early‐stage type 2 diabetes
por: Hirukawa, Hidenori, et al.
Publicado: (2018)

Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type 2 diabetes (JDDM70)
por: Shirabe, Shinichiro, et al.
Publicado: (2022)

Drug Transport Mechanism of Oral Antidiabetic Nanomedicines
por: Gundogdu, Evren, et al.
Publicado: (2014)

The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010
por: Guthrie, Bruce, et al.
Publicado: (2015)

Phyto diab care: Phytoremedial database for antidiabetics
por: Luhach, Shruti, et al.
Publicado: (2013)

Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs
por: Klatt, Sabine, et al.
Publicado: (2011)

Polypharmacy and potential drug–drug interactions for people with HIV in the UK from the Climate‐HIV database
por: Okoli, C, et al.
Publicado: (2020)

Incidence and predictors of hypoglycemia in Japanese patients with type 2 diabetes treated by insulin glargine and oral antidiabetic drugs in real-life: ALOHA post-marketing surveillance study sub-analysis
por: Odawara, Masato, et al.
Publicado: (2014)

Changes in psychotropic polypharmacy and high‐potency prescription following policy change: Findings from a large scale Japanese claims database
por: Takeshima, Masahiro, et al.
Publicado: (2022)

How many oral antidiabetic drugs before insulin?
por: Kelwade, Jayant, et al.
Publicado: (2017)

Selective Insulin Receptor Modulators (SIRM): A New Class of Antidiabetes Drugs?
por: Vigneri, Riccardo, et al.
Publicado: (2012)

Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
por: Cheung, BMY, et al.
Publicado: (2020)

Characterising the evolution of antipsychotic polypharmacy and clozapine prescribing patterns in schizophrenia patients during psychiatric hospitalisations
por: Lagreula, J., et al.
Publicado: (2022)

Antidiabetic Action of Bezafibrate in a Large Observational Database
por: Flory, James H., et al.
Publicado: (2009)

DIACAN: Integrated Database for Antidiabetic and Anticancer Medicinal Plants
por: James, Priyanka, et al.
Publicado: (2013)

Impact of Polypharmacy on the Rehabilitation Outcome of Japanese Stroke Patients in the Convalescent Rehabilitation Ward
por: Kose, Eiji, et al.
Publicado: (2016)

Comparative effectiveness of incident oral antidiabetic drugs on kidney function
por: Hung, Adriana M, et al.
Publicado: (2012)

Efficacy and Safety of Metformin Versus the Other Oral Antidiabetic Drugs in Japanese Type 2 Diabetes Patients: A Network Meta-analysis
por: Nishimura, Rimei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fumo18hk3gbsb5gjccq4rcksd6